Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Enregistré dans:

Détails bibliographiques
Collectivité auteur:	Council for International Organizations of Medical Sciences (CIOMS)
Format:	Livre
Langue:	English
Publié:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Sujets:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Accès en ligne:	Visit NHRC Library
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Martindale: the complete drug reference
par: Parfitt, Kathleen
Publié: (1999)

WHO drug information.
Publié: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Publié: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publié: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Publié: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Publié: (2012)

USP DI. Approved drug products and legal requirements.
Publié: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
par: Andersson, Sarah
Publié: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Publié: (1997)

Pharmacology : a patient-centered nursing process approach /
par: Kee, Joyce LeFever, et autres

Drug calculations : ratio and proportion problems for clinical practice /
par: Seltzer, Meta Brown, et autres

Effective drug regulation a multicountry study /
par: Ratanawijitrasin, Sauwakon
Publié: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
par: DEVS Consult Nepal (P) Ltd.
Publié: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
par: Acharya,Kiran
Publié: (2018)

Regulatory Situation of Herbal Medicines
Publié: (1998)

A text book of pharmacognosy.
par: Raut, Bechan, et autres
Publié: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
par: Adhikari, SM, et autres
Publié: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Publié: (2012)

AHFS drug information 2000
par: Snow, Elaine, K
Publié: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Publié: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
par: Nepal Health Research Council (NHRC), et autres
Publié: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
par: Yadav, Raju
Publié: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Publié: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
par: Brody, Tom
Publié: (2016)

Evaluation of certain veterinary drug residues in food
Publié: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
par: Aryal, BK, et autres
Publié: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
par: Pande, Sarala
Publié: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
par: Adhikari, Shyam Mani
Publié: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
par: Adhikari, Shyam Mani, Dr.
Publié: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Publié: (1995)

Fundamentals of Clinical Trials /
par: Friedman, Lawrence M, et autres
Publié: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Publié: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Publié: (2000)

Drug policy in the Americas
par: Smith, Peter H.
Publié: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publié: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publié: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
par: Poudel, Krishna Prasad
Publié: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
par: Maskay, NM, et autres
Publié: (2016)